The use of angiotensin II receptor blocker is associated with greater recovery of cardiac function than angiotensin‐converting enzyme inhibitor in dilated cardiomyopathy

Abstract Aims Angiotensin‐converting enzyme inhibitors (ACEis) or angiotensin II receptor blockers (ARBs) have been shown to be associated with recovery of cardiac function in patients with dilated cardiomyopathy (DCM). The aim of this study was to assess comparative effectiveness of ACEis vs. ARBs...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Nobuyuki Enzan, Shouji Matsushima, Tomomi Ide, Takeshi Tohyama, Kouta Funakoshi, Taiki Higo, Hiroyuki Tsutsui
Format:	Artigo
Jezik:	Inglês
Izdano:	Oxford University Press 2022-04-01
Serija:	ESC Heart Failure
Teme:	Dilated cardiomyopathy Heart failure with reduced ejection fraction Angiotensin‐converting enzyme inhibitor Angiotensin II receptor blocker
Online dostop:	https://doi.org/10.1002/ehf2.13790
Oznake:	Označite Brez oznak, prvi označite!